Cellular implantation for the treatment of chronic pain

Pain: Current Understanding, Emerging Therapies, and Novel Approaches to Drug Discovery

Volumn , Issue , 2003, Pages 815-833

  Sagen, Jacqueline ^a   Eaton, Mary ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 5644256580     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (81)

1. Unsicker K. The trophic cocktail made by adrenal chromaffin cells. Exp Neurol 1993; 123: 167-173.
2. Czech KA, Pollak R, Pappas GD, Sagen J. Bovine chromaffin cells for CNS transplants do not elicit xenogeneic T cell proliferative responses in vitro. Cell Transplant 1996; 5:257-267.
3. Schueler SB, Sagen J, Pappas GD, Kordower JH. Long-term viability of isolated bovine adrenal medullary chromaffin cells following intrastriatal transplantation. Cell Transplant 1995; 4:55-64.
4. Michalewicz P, Laurito CE, Pappas GD, Lu Y, Yeomans DC. Purification of adrenal chromaffin cells increases antinociceptive efficacy of xenotransplants without immunosuppression. Cell Transplant 1999; 8: 103-109.
5. Ortega-Alvaro A, Gibert-Rahola J, Chover AJ, Tejedor-Real P, Casas J, Mico JA. Effect of amitriptyline on the analgesia induced by adrenal medullary tissue transplanted in the rat spinal subarachnoid space as measured by an experimental model of acute pain. Exp Neurol 1994; 130: 9-14.
6. Ruz-Franzi JI, Gonzalez-Darder IM. Study of the analgesic effects of the implant of adrenal medullary into the subarachnoid space in rats. Acta Neurochir 1991; 52:39-41.
7. Sagen J, Pappas GD, Perlow MJ. Adrenal medullary tissue transplants in rat spinal cord reduce pain sensitivity. Brain Res 1986; 384:189-194.
8. Sagen J, Pappas GD, Pollard HB. Analgesia induced by isolated bovine chromaffin cells implanted in the rat spinal cord. Proc Natl Acad Sci USA 1986; 83:7522-7526.
9. Sagen J, Wang H, Tresco PA, Aebischer P. Transplants of immunologically isolated xenogeneic chromaffin cells provide a long-term source of pain reducing neuroactive substances. J Neurosci 1993; 13:2415-2423.
10. Wang H, Sagen J. Optimization of adrenal medullary allograft conditions for pain alleviation. J Neural Transplant Plast 1994; 5:49-64.
11. Ortega-Alvaro A, Gibert-Rahola J, Mellado-Femandez ML, Chover AI, Mica JA. The effects of different monoaminergic antidepressants on the analgesia induced by spinal cord adrenal medullary transplants in the formalin test in rats. Anesth Analg 1997; 84:816-820.
12. Sagen J, Wang H, Pappas GD. Adrenal medullary implants in rat spinal cord reduce nociception in a chronic pain model. Pain 1990; 42:69-79.
13. Siegan JB, Sagen J. Attenuation of formalin pain responses in the rat by adrenal medullary transplants in the spinal subarachnoid space. Pain 1997; 70:279-285.
14. Vaquero J, Arias A, Oya S, Zurita M. Chromaffin allografts into arachnoid of spinal cord reduce basal pain responses in rats. Neuro report 1991; 2:149-151.
15. Wang H, Sagen J. Attenuation of pain-related hyperventilation in adjuvant arthritic rats with adrenal medullary transplants in the spinal subarachnoid space. Pain 1995; 63:313-320.
16. Decosterd I, Buchser E, Gilliard N, Saydoff J, Zum AD, Aebischer P. Intrathecal implants of bovine chromaffin cells alleviate mechanical allodynia in a rat model of neuropathic pain. Pain 1998; 76: 159-166.
17. Ginzburg R, Seltzer Z. Subarachnoid spinal cord transplantation of adrenal medulla suppresses chronic neuropathic pain behavior in rats. Brain Res 1990; 523:147-150.
18. Hama AT, Sagen J. Reduced pain-related behavior by adrenal medullary transplants in rats with experimental painful peripheral neuropathy. Pain 1993; 52:223-231.
19. Hama AT, Sagen J. Alleviation of neuropathic pain symptoms by xenogeneic chromaffin cell grafts in the spinal subarachnoid space. Brain Res 1994; 651:345-351.
20. Brewer KL, Yezierski RP. Effects of adrenal medullary transplants on pain-related behaviors following excitotoxic spinal cord injury. Brain Res 1998; 798:83-92.
21. Hains BC, Chastain KM, Everhart AW, Hulsebosch CE. Reduction of chronic central pain following spinal cord injury by transplants of adrenal medullary chromaffin cells. Soc Neurosci Abstr 1998; 24:1631.
22. Yu W, Hao J-X, Xu X-J, Saydoff J, Haegerstrand A, Wiesenfeld-Hallin Z. Long-term alleviation of allodynia-like behaviors by intrathecal implantation of bovine chromaffin cells in rats with spinal cord injury. Pain 1998; 74:115-122.
23. Yu W, Hao J-X, Xu X-J, Saydoff J, Haegerstrand A, Wiesenfeld-Hallin Z. Immunoisolating encapsulation of intrathecally implanted bovine chromaffin cells prolongs their survival and produces antiallodynic effect in spinally injured rats. Eur J Pain 1998; 2:143-151.
24. Schueler SB, Ortega JD, Sagen J, Kordower JH. Robust survival of isolated bovine adrenal chromaffin cells following intrastriatal transplantation: a novel hypothesis of adrenal graft viability. J Neurosci 1993; 13:4496-4510.
25. Yezierski RP, Uu S, Ruenes GL, Kajander KJ, Brewer KL. Behavioral and pathological characteristic of a central pain model following spinal cord injury. Pain 1998; 75:141-155.
26. Siegan JB, Sagen J. Attenuation of NMDA-induced spinal hypersensitivity by adrenal medullary transplants. Brain Res 1995; 680:88-98.
27. Haley IE, Sullivan AF, Dickenson AH. Evidence for spinal N-methyl-D-aspartate receptor involvement in prolonged chemical nociception in the rat. Brain Res 1990; 518:218-226.
28. Hunter JC, Singh L. Role of excitatory amino acid receptors in the mediation of the nociceptive response to formalin in the rat. Neurosci Lett 1994; 174:217-221.
29. Malmberg AB, Yaksh TL. Spinal nitric oxide synthesis inhibition blocks NMDA-induced thermal hyperalgesia and produces antinociception in the formalin test in rats. Pain 1993; 54:291-300.
30. Vaccarino AL, Marek P, Kest B, Weber E, Keana JFW, Liebeskind JC.NMDA receptor antagonists, MK-80l and ACEA-1011, prevent the development of tonic pain following subcutaneous formalin. Brain Res 1993; 615:331-334.
31. Yamamoto T, Yaksh TL. Comparison of the antinociceptive effects of pre-and posttreatment with intrathecal morphine and MK80l, an NMDA antagonist, on the formalin test in the rat. Anesthesiology 1992; 77:757-763.
32. Malmberg AB, Yaksh TL. Pharmacology of the spinal action of ketorolac, morphine, ST-91, U50488H, and L-PIA on the formalin test and an isobolographic analysis of the NSAID interaction. Anesthesiology 1993; 79:270-281.
33. Lemaire S, Shukla VJ, Rogers C, Ibrahim IH, Lapierre C, Parent P, Dumont M. Isolation and characterization of histogranin, a natural peptide with NMDA receptor antagonist activity. Eur J Pharmacol 1993; 245:247-256.
34. Siegan JB, Sagen J. A natural peptide with NMDA inhibitory activity reduces tonic pain in the formalin model. Neuroreport 1997; 8:1379-1381.
35. Siegan JB, Hama AT, Sagen J. Suppression of neuropathic pain by a naturally-derived peptide with NMDA antagonist activity. Brain Res 1997; 755:331-334.
36. Hama AT, Siegan JB, Herzberg U, Sagen J. NMDA-induced spinal hypersensitivity is reduced by naturally-derived peptide analog [Serl]histogranin. Pharmaco1 Biochem Behav 1998; 62:67-74.
37. Hama A, Sagen J. Induction of a spinal NADPH-diaphorase by nerve injury is attenuated by adrenal medullary transplants. Brain Res 1994; 640:345-351.
38. Siegan JB, Hama AT, Sagen J. Alterations in spinal cord cGMP by peripheral nerve injury and adrenal medullary transplantation. Neurosci Lett 1996; 215:49-52.
39. Sagen J, Wang H. Adrenal medullary grafts suppress c-fos induction in spinal neurons of arthritic rats. Neurosci Lett 1995; 192:1-4.
40. Siegan JB, Frydel BR, Sagen J. Attenuation of spinal c-fos activation in the formalin model by adrenal medullary implants. Am Pain Soc Abstr 1996; l5:A-46.
41. Lachmund A, Gehrke D, Krieglstein K, Unsicker K. Trophic factors from chromaffin granules promote survival of peripheral and central nervous system neurons. Neuroscience 1994; 62:361370.
42. Hama AT, Pappas GD, Sagen J. Adrenal medullary implants reduce transsynaptic degeneration in the spinal cord of rats following chronic constriction nerve injury. Exp Neurol 1996; 137:81-93.
43. Ibuki T, Hama AT, Wang X-T, Pappas GD, Sagen J. Loss of GABA immunoreactivity in the spinal dorsal horn of rats with peripheral nerve injury and promotion of recovery by adrenal medullary grafts. Neuroscience 1997; 76:845-858.
44. Ralston DD, Coyle DE, Tedesco CS, Milroy AM, Ralston HJ. Long term changes in GABA immunoreactivity (GABA-ir) in a rat model of peripheral mononeuropathy. Soc Neurosci Abstr 1997; 23: 1533.
45. Sugimoto T, Bennett GJ, Kajander KC. Transsynaptic degeneration in the superficial dorsal horn after sciatic nerve injury: effects of chronic constriction injury, transection, and strychnine. Pain 1990; 42:205-213.
46. Winnie AP, Pappas GD, Das Gupta TK, Wang H, Ortega JD, Sagen J. Alleviation of cancer pain by adrenal medullary transplants in the spinal subarachnoid space: a preliminary report. Anesthesiology 1993; 79:644-653.
47. Lazorthes Y, Bes JC, Sagen J, Tafani M, Tkaczuk J, Sallerin B, Nahri I, Verdie JC, Ohayon E, Caratero C, Pappas GD. Transplantation of human chromaffin cells for control of intractable cancer pain. Acta Neurochir 1995; 64:97-100.
48. Vaquero J, Martinez R, Oya S, Coca S, Salazer FG, Colado MI. Transplantation of adrenal medulla into spinal cord for pain relief: disappointing outcome. Lancet 1988; 2:1315.
49. Aebischer P, Buchser E, Joseph IM, Favre J, de Tribolet N, Lysaght M, Rudnick S, Goddard M. Transplantation in humans of encapsulated xenogeneic cells without immunosuppression. Transplantation 1994; 58:1275-1277.
50. Buchser E, Goddard M, Heyd B, Joseph JM, Favre J, Detribolet N, Lysaght M, Aebischer P. Immunoisolated xenogeneic chromaffin cell therapy for chronic pain: initial experience. Anesthesiology 1996; 85: 1005-1012.
51. Burgess FW, Goddard M, Savarese D, Wilkinson H. Subarachnoid bovine adrenal chromaffin cell implants for cancer pain management. Am Pain Soc Abstr 1996; 15:A-33.
52. Deleted in proof.
53. Hefti F, Hartikka J, Schlumpf M. Implantation of PC12 cells into the corpus striatum of rats with lesions of the doparninergic nigrostriatal neurons. Brain Res 1985; 348:283-288.
54. Jaeger CB. Morphological and immunocytochemical characteristics ofPCI2 cell grafts in rat brain. Ann NY Acad Sci 1987; 495:334-350.
55. Kordower JH, Liu Y, Winn S, Emerich D. Encapsulated PCI2 cell transplants into hemiparkinsonian monkeys: a behavioral, neuroanatomical, and neurochemical analysis. Cell Transplant 1995; 4:155171.
56. Pappas GD, Sagen J. Fine structure of PC 12 cell implants in the rat spinal cord. Neurosci Lett 1986; 70:59-64.
57. Rohrer D, Nilaver G, Nipper V, Machida C. Genetically modified PCI2 brain grafts: survivability and inducible nerve growth factor expression. Cell Transplant 1996; 5:57-68.
58. Greene LA, Tischler AS. Establishment of a noradrenergic clonal cell line of rat adrenal pheochromocytoma cells which respond to NGF. Proc Natl Acad Sci USA 1976; 73:2424-2428.
59. Saitoh Y, Eguchi Y, Hagihara Y, Arita N, Watahiki M, Tsujimoto Y, Hayakawa T. Dose-dependent doxycycline-mediated adrenocorticotropic hormone secretion from encapsulated Tet-on proopiomelanocortin Neuro2A cells in the subarachnoid space. Hum Gene Ther 1998; 9:997-1002.
60. Saitoh Y, Taki T, Arita N, Ohnishi T, Hayakawa T. Analgesia induced by transplantation of encapsulated tumor cells secreting β-endorphin. J Neurosurg 1995; 82:630-634.
61. Saitoh Y, Taki T, Arita N, Ohnishi T, Hayakawa T. Cell therapy with encapsulated xenogeneic tumor cells secreting β-endorphin for treatment of peripheral pain. Cell Transplant 1995; 4 (suppll):S13S17.
62. Wu HH, McLoon SC, Wilcox GL. Antinociception following implantation of AtT-20 and genetically modified AtT-20/hENK cells in rat spinal cord. J Neural Transplant Plast 1993; 4:15-26.
63. Wu HH, Wilcox GL, McLoon SC. Implantation of AtT-20 or genetically modified AtT-20-hENK cells in mouse spinal cord induced antinociception and opioid tolerance. J Neurosci 1994; 14:48064814.
64. Bredesen DE, Hisanaga MD, Sharp FA. Neural transplantation using temperature sensitive immortalized neural cells: a preliminary report. Ann Neurol 1990; 27:205-207.
65. Giordano M, Takashima H, Herranz A, Poltorak M, Geller HM, Marone M, Freed WJ. Immortalized GAB Aergic cell lines derived from rat striatum using a temperature-sensitive allele of the SV40 large T antigen. Exp Neurol 1993; 124:395-400.
66. Giotta GJ, Heitzmann J, Cohn M. Properties of two temperature-sensitive Rous sarcoma virus transformed cerebellar cell lines. Brain Res 1980; 202:445-458.
67. Jat PS, Sharp PA. Cell lines established by a temperature-sensitive simian virus 40 large T antigen gene are growth restricted at nonperrnissive temperature. Mol Cell BioI 1989; 9:1672-1681.
68. Frederiksen K, Jat PS, Valtz N, Levy D, McKay R. Immortalization of precursor cells from the mammalian CNS. Neuron 1988; 1:439-448.
69. Frederiksen K, McKay RDG. Proliferation and differentiation of rat neuroepithelial precursor cells in vivo. J Neurosci 1988; 8:1144-1151.
70. Selmaj K, Raine CS, Farooq M, Norton WT, Brosnan CF. Cytokine cytotoxicity against oligodendrocytes: apoptosis induced by Iymphotoxin. J Immunol 1991; 147:1522-1529.
71. Whittemore SR, White LA. Target regulation of neuronal differentiation in a temperature-sensitive cell line derived from medullary raphe. Brain Res 1993; 615:27-40.
72. Eaton MJ, Staley JK, Globus MYT, Whittemore SR. Developmental regulation of early serotonergic neuronal differentiation: the role of brain-derived neurotrophic factor and membrane depolarization. Dev BioI 1995; 170:169-182.
73. Eaton MJ, Whittemore SR. ACTH activation of adenylate cyclase in raphe neurons: multiple regulatory pathways control serotonergic neuronal differentiation. J Neurobiol 1995; 28:465-481.
74. Eaton MJ, Whittemore SR. Autocrine BDNF secretion enhances the survival and serotonergic differentiation of raphe neuronal precursor cells grafted into the adult rat CNS. Exp Neurol 1996; 140: 105-114.
75. Eaton MJ, Dancausse HR, Santiago DI, Whittemore SR. Lumbar transplants of immortalized serotonergic neurons alleviates chronic neuropathic pain. Pain 1997; 72:59-69.
76. Eaton MJ, Plunkett JA, Martinez MA, Lopez T, Karmally S, Cejas P, Whittemore SR. Transplants of neuronal cells bio-engineered to synthesize GABA alleviate chronic neuropathic pain. Cell Transplant 1999; 8:87-101.
77. Bennett GJ, Xie Y-K. A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain 1988; 33:87-107.
78. Birren SJ, Anderson DJ. A v-myc-immortalized sympathoadrenal progenitor cell line in which neuronal differentiation is initiated by FGF not by NGF. Neuron 1990; 4:189-201.
79. Sufi C, Fung BP, Tischler AS, Chikaraishi DM. Catecholaminergic cell lines from the brain and adrenal glands of tyrosine hydroxylase-SV40 T antigen transgenic mice. J Neurosci 1993; 13:12801291.
80. Frydel B, Eaton MJ, Lopez RF, Nie XT, Sagen J. Generation and characterization of conditionally immortalized chromaffin cell lines. Am Soc Neural Transplant 1999; 6:55.
81. Eaton MJ, Lopez TF, Frydel BR, Martinez MA, Sagen J. Transplants of immortalized chromaffin cells for neuropathic pain. Am Soc Neural Transplant 1999; 6:55.